NEXTSEQ 2000 SILVER SUPPORT PLAN

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Department of Health and Human Services intends to award a firm fixed price sole source contract under the authority of FAR subpart 13.106-1(b)(1)(i), for purchases not exceeding the Simplified Acquisition Threshold (SAT), Contracting Officers may solicit from only one source if the circumstances deem only one source is reasonably available (e.g., urgency, exclusive licensing agreements, brand name, or industrial mobilization).: Illumina, Inc. 

The North American Industry Classification System (NAICS) code for this requirement is 811210, Electronic and Precision Equipment Repair and Maintenance, and the Product Service Code (PSC) is J066, Maintenance, Repair, and Rebuilding of Equipment- Instruments and Laboratory Equipment.

The object of this sole source award is an instrument which requires annual cleaning, replacement parts, and software upgrades to the built-in operating computer. Illumina is the sole source for many of the parts and for all the software. The maintenance and support for DNA sequencer NextSeq2000 provides annual equipment necessary to maintain and provide preventive maintenance for the following equipment: DNA Sequencer Next 2000.

This synopsis does not constitute a solicitation, however interested parties may identify their interests and capability to respond to this requirement within three (3) calendar days of the publication of this notice. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Information received will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. A determination by the Government not to compete this procurement based upon response to this notice is solely within the discretion of the Government. No reimbursement for any cost connected with providing capability information will be provided.

Capability statements shall be submitted by e-mail ONLY to the following address: Shannon.scarboro@hhs.gov.